Effect of Copanlisib on Metformin Pharmacokinetics and Pharmacodynamics

NCT03655301 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Copanlisib (Aliqopa, BAY80-6946)
DRUG: Metformin

Sponsor

Bayer